Listing 1 - 2 of 2 |
Sort by
|
Choose an application
Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antiplatelet field, and have also had very little in the way of competition until recently; although a number of parenteral anticoagulants have been available, the vitamin K antagonists have been the only orally active anticoagulant drugs. The last few years have seen the arrival of new drug classes, the orally active direct thrombin inhibitors and factor Xa antagonists, which offer a number of advantages, but not without important drawbacks. In the face of these important advances in both antiplatelet and anticoagulant therapy, clinicians often feel confused, even overwhelmed, as to what is now available and which drugs are useful (and indicated) in which circumstances. Antiplatelet and Anticoagulant Therapy is designed with such people in mind. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
Anticoagulants (Medicine). --- Anticoagulants (Medicine) --- Blood --- Blood platelets --- Blood coagulation disorders --- Biological Factors --- Hematologic Agents --- Vascular Diseases --- Embolism and Thrombosis --- Cardiovascular Diseases --- Therapeutic Uses --- Chemicals and Drugs --- Diseases --- Pharmacologic Actions --- Chemical Actions and Uses --- Thrombosis --- Platelet Aggregation Inhibitors --- Blood Coagulation Factor Inhibitors --- Arterial Occlusive Diseases --- Medicine --- Health & Biological Sciences --- Hematologic Diseases --- Pharmacy, Therapeutics, & Pharmacology --- Coagulation --- Chemotherapy --- Blood platelets. --- Antithrombotic agents --- Blood thinners --- Blood thinning drugs --- Platelets --- Thrombocytes --- Medicine. --- Cardiology. --- Medicine & Public Health. --- Medicine/Public Health, general. --- Hematologic agents --- Blood cells --- Megakaryocytes --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Heart --- Internal medicine --- Health Workforce
Choose an application
"With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis"--Publisher's description.
Blood coagulation disorders. --- Anticoagulants (Medicine) --- Blood platelet disorders. --- Fibrinolytic agents. --- Hemostasis --- Thrombosis --- Blood Coagulation Disorders. --- Blood Platelet Disorders. --- Fibrinolytic Agents --- Anticoagulants --- Physiological aspects. --- Pathophysiology. --- pathology. --- physiology. --- therapeutic use.
Listing 1 - 2 of 2 |
Sort by
|